JanOne Inc. (NASDAQ: JAN)
$2.26
+0.0300 ( +1.34% ) 139.6K
JanOne Inc is focused on being a clinical-stage pharmaceutical company committed to finding treatments for conditions that cause severe pain and bringing drugs to market with non-addictive pain-relieving properties. One of the Company's goals is to reduce the need for prescriptions for dangerous opioid drugs by treating underlying diseases that cause severe pain. The company operates in two operating segments, namely Biotechnology, and discontinued operations.
Market Data
Open
$2.26
Previous close
$2.23
Volume
139.6K
Market cap
$27.14M
Day range
$2.10 - $2.36
52 week range
$0.22 - $5.26
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Mar 15, 2024 |
8-k | 8K-related | 16 | Feb 28, 2024 |
8-k/a | 8K-related | 18 | Feb 09, 2024 |
8-k | 8K-related | 18 | Feb 08, 2024 |
8-k | 8K-related | 13 | Jan 12, 2024 |
10-q | Quarterly Reports | 86 | Nov 14, 2023 |
8-k | 8K-related | 12 | Oct 11, 2023 |
8-k/a | 8K-related | 13 | Sep 22, 2023 |
8-k | 8K-related | 12 | Sep 15, 2023 |
def | Proxies and info statements | 7 | Aug 28, 2023 |